Screening option reduces bowel cancer risk for up to 17 years

Findings that a single flexible sigmoidoscopy exam in 55-64 years olds confers long-lasting protection against colorectal cancer are unlikely to change clinical practice in Australia, an expert says. The UK Flexible Sigmoidoscopy Screening Trial (UKFSST) of over 170,000 people found the intervention reduced colorectal cancer incidence by 26% and colorectal cancer mortality by 30% for ...

Already a member?

Login to keep reading.

© 2021 the limbic